TriSalus Life Sciences Statistics
Total Valuation
TLSI has a market cap or net worth of $280.22 million. The enterprise value is $270.03 million.
| Market Cap | 280.22M |
| Enterprise Value | 270.03M |
Important Dates
The next estimated earnings date is Wednesday, May 15, 2024, before market open.
| Earnings Date | May 15, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TLSI has 30.10 million shares outstanding. The number of shares has increased by 2,934.71% in one year.
| Shares Outstanding | 30.10M |
| Shares Change (YoY) | +2,934.71% |
| Shares Change (QoQ) | -28.68% |
| Owned by Insiders (%) | 54.40% |
| Owned by Institutions (%) | 11.88% |
| Float | 17.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15.14 |
| Forward PS | 8.96 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 14.59 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.42
| Current Ratio | 1.42 |
| Quick Ratio | 1.04 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3,688.31 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -246.20% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $165,277 |
| Profits Per Employee | -$527,125 |
| Employee Count | 112 |
| Asset Turnover | 0.77 |
| Inventory Turnover | 1.30 |
Taxes
In the past 12 months, TLSI has paid $9,000 in taxes.
| Income Tax | 9,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (1Y) | 0.65 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 9.60 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 43.75 |
| Average Volume (30 Days) | 41,545 |
Short Selling Information
The latest short interest is 276,294, so 0.92% of the outstanding shares have been sold short.
| Short Interest | 276,294 |
| Short Previous Month | 287,412 |
| Short % of Shares Out | 0.92% |
| Short % of Float | 1.62% |
| Short Ratio (days to cover) | 6.19 |
Income Statement
In the last 12 months, TLSI had revenue of $18.51 million and -$59.04 million in losses. Loss per share was -$6.73.
| Revenue | 18.51M |
| Gross Profit | 15.91M |
| Operating Income | -54.53M |
| Pretax Income | -59.03M |
| Net Income | -59.04M |
| EBITDA | -58.31M |
| EBIT | -59.01M |
| Loss Per Share | -$6.73 |
Balance Sheet
The company has $11.78 million in cash and $1.60 million in debt, giving a net cash position of $10.18 million or $0.34 per share.
| Cash & Cash Equivalents | 11.78M |
| Total Debt | 1.60M |
| Net Cash | 10.18M |
| Net Cash Per Share | $0.34 |
| Equity / Book Value | -25.94M |
| Book Value Per Share | -0.86 |
| Working Capital | 6.18M |
Cash Flow
In the last 12 months, operating cash flow was -$50.05 million and capital expenditures -$1.12 million, giving a free cash flow of -$51.17 million.
| Operating Cash Flow | -50.05M |
| Capital Expenditures | -1.12M |
| Free Cash Flow | -51.17M |
| FCF Per Share | -$5.45 |
Margins
Gross margin is 85.93%, with operating and profit margins of -294.58% and -318.93%.
| Gross Margin | 85.93% |
| Operating Margin | -294.58% |
| Pretax Margin | -318.89% |
| Profit Margin | -318.93% |
| EBITDA Margin | -315.01% |
| EBIT Margin | -318.80% |
| FCF Margin | -276.41% |
Dividends & Yields
TLSI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2,934.71% |
| Shareholder Yield | -2,934.71% |
| Earnings Yield | -21.07% |
| FCF Yield | -18.26% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | 44.63% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TLSI has an Altman Z-Score of -16.83 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -16.83 |
| Piotroski F-Score | 5 |